Boundary Holding
VC Fund
Luxembourg, Belgium
Boundary Holding is a VC fund in Luxembourg focused on Drones and Robotics. Headquarters: 121 , Avenue de la Faïencerie, 1511, LUXEMBOURG .Boundary Holding is a global investment fund based out of Luxembourg and France which invests in Artificial Intelligence, and associated next-gen industries like Deep Tech, IoT and Analytics. Primarily operating as a Bridge fund, Boundary Holding was founded by Rajat Khare. The fund hasa network of startup programs around the world in AI and Analytics across different organizations in the world.The company seeks to investing in efficient business models of startups in the associated next-gen technologies, which has the potential to further grab market opportunities, whilst maintaining allegiance towards the entrepreneurial roots and ideals.
- Total investments:
- 48
- Last investment:
- Lead investor:
- 17%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Boundary Holding invests in
Stages Boundary Holding invests in
Countries Boundary Holding invests in
Round sizes
Round size
- Seed
- $18k–$4.4M
Investment Focus
Industry
- Drones 9 (19%)
- Robotics 7 (15%)
- Artificial Intelligence 7 (15%)
- Aerospace 5 (10%)
- Security 4 (8%)
Stage
- Seed 18 (38%)
- Series A 7 (15%)
- Series B 5 (10%)
- Venture - Series Unknown 5 (10%)
- Funding Round 3 (6%)
Country
- Switzerland 7 (15%)
- India 6 (13%)
- France 5 (10%)
- Germany 5 (10%)
- United Kingdom 2 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aero41 is developing a drone entirely dedicated to crop protection, a flexible and intelligent platform that will integrate AI and collect data to make crop protection more and more eco-responsible while being effective to ensure the necessary yields. | Seed / Sep 01, 2022 | ||
| Remidio is engaged in designing & developing Smart, Innovative & Disruptive Imaging Technologies in Vision Care, using a product development approach called “Design Thinking”.As part of the Design Thinking process, Remidio takes into account different facets of a customer’s experience with a product, as part of its overall productdesign approach, with the intent of inventing a new customer experience with the product.Customers can be an amazing resource to glean insight and understanding, but they are generally not able to articulate their latent and anticipated needs. Remidio hence focuses on making quick functional prototypes, that can then be given to the customer to understand these latent needs while observing their use of the prototypes.Founded by professionals with a passion for product innovation, Remidio is currently focussed on creating game changing products and solutions in the ophthalmology space.We look at constraints posed by a developing nation context- infrastructure, skilled resources and affordable pricing as an opportunity to innovate.We bring to market very high quality products that are reliable and extremely simple to use. | Seed / Mar 31, 2022 | ||
| Neo aims at transforming the current approach to spinal surgery by providing a unique answer to the worldwide strive for healthcare cost optimization through efficient, versatile and high quality systems. | Seed / Jan 28, 2022 | ||
| CYSEC is a startup working on next generation Confidential Computing solutions securing data at rest, in motion and in use. Currently they have released their ARCA solution which is quickly becoming one of the more popular choices in the market. | $4.4M / Seed / Jan 20, 2022 | ||
| Kido Dynamics provides tools for companies to deeply understand people’s mobility patterns. Our technology provides exhaustive, contextual analytics for people mobility patterns. Demand for such tools is very broad all over the world, including segments such as transportation, out-of-home marketing, tourism, events, and smart cities. KidoDynamics technology (inspired in computational physics) is specifically created to analyze mobility data, and it extracts the maximum of useful information, reducing cost, deployment time and months of development and investment in data scientists. | $2.1M / Nov 22, 2021 | ||
| Kido Dynamics provides tools for companies to deeply understand people’s mobility patterns. Our technology provides exhaustive, contextual analytics for people mobility patterns. Demand for such tools is very broad all over the world, including segments such as transportation, out-of-home marketing, tourism, events, and smart cities. KidoDynamics technology (inspired in computational physics) is specifically created to analyze mobility data, and it extracts the maximum of useful information, reducing cost, deployment time and months of development and investment in data scientists. | $2.1M / Seed / Nov 22, 2021 | ||
| Skilancer is a centrally controlled, self-powered, robot for automatic cleaning of solar panels with elements of Artificial Intelligence.The company is a brainchild of IIT Jodhpur alumni Neeraj Kumar with 3 years of work experience in the solar industry and Manish Kumar Das, an instrumentation engineer with 10 years of experience. Skilancer is inan industrial collaboration with Amity University. | Seed / Nov 20, 2021 | ||
| Defendec is an innovative company specializing in the development of world-class remote premises surveillance technology. The company operates globally with offices in Washington, D.C, Singapore, Estonia. Defendec's main product, Smartdec, is securing NATO’s and European Union's external borders. It is currently operationalworldwide. Smartdec helps stop international smuggling, illegal trafficking, and acts of sabotage every day making it the technology of choice among border guards. | Series A / Oct 27, 2021 | ||
| Orgenesis is a development stage company with a novel therapeutic approach in the treatment of diabetes by correcting malfunctioning organs with new functional tissues created from the patient’s own existing organs. Orgenesis employs a molecular and cellular approach directed at converting liver cells into functional insulin-producing cells as atreatment for diabetes. This new therapeutic approach is called Autologous Insulin Producing (AIP) cell transplantation.Beta cell replacement is one of the most promising approaches for treatment of Insulin Dependent Diabetes Mellitus (IDDM). Currently, pancreas islet transplantation is the only approved cell replacement technology and it's the best available treatment for diabetics. However, it's impractical because of a shortage of donor tissue and rejection rate by the patient' immune system. Orgenesis believes that converting the diabetic patients own tissue to insulin producing cells will overcome the problem of donor shortage. Moreover, since the diabetic patient serves as his/her own donor, there is no risk of transplant rejection.Orgenesis has manifested promising results in in-vitro and in-vivo studies using human liver tissues. Based on this significant discovery and these findings, Orgenesis has designed an efficient and clear work-plan to initiate clinical testing in the next few months allowing the company to launch phase I clinical trials following FDA guidelines followed by the launch of Phase II clinical trials within a year. | Post-IPO Equity / Sep 28, 2021 | ||
| Market leader in drone charging, leveraging patented (September 2024) cross-platform docking and charging technology, to deliver fully integrated charging stations able to power and automate any —current, future, or legacy— drone model thorugh one unified infrastructure. Our tech is being piloted by some of the largest infrastructure clients, dronemanufacturers and the first defense contractors. | Seed / Sep 28, 2021 | ||
| See all 48 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Boundary Holding invest in?
Boundary Holding invests primarily in Drones, Robotics and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 48 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Boundary Holding's check size?
Boundary Holding typically joins rounds of $18k–$4.4M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Boundary Holding participates in.
When did Boundary Holding last invest?
The most recent investment recorded for Boundary Holding closed in Sep 2022. Shizune tracks 48 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
